10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021.

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                   to                 .

Commission File Number   1-12273

ROPER TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware		51-0263969
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
6901 Professional Pkwy., Suite 200
Sarasota,	Florida	34240
(Address of principal executive offices)		(Zip Code)

(941) 556-2601

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange On Which Registered
Common Stock, $0.01 Par Value	ROP	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes   ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes   ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☒	Large accelerated filer	☐	Accelerated filer
☐	Non-accelerated filer (Do not check if a smaller reporting company)	☐	Smaller reporting company
		☐	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ☐ Yes    ☒ No

The number of shares outstanding of the registrant’s common stock as of April 30, 2021 was 105,239,028.

1

ROPER TECHNOLOGIES, INC.

REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited):
	Condensed Consolidated Statements of Earnings	3
	Condensed Consolidated Statements of Comprehensive Income	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Cash Flows	6
	Condensed Consolidated Statements of Changes in Stockholders' Equity	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 6.	Exhibits	24
	Signatures	25

2

PART I.    FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

Roper Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Earnings (unaudited)

(in millions, except per share data)

	Three months ended March 31,
	2021		2020
Net revenues	$	1,528.6	$	1,350.7
Cost of sales	534.8		493.9
Gross profit	993.8		856.8
Selling, general and administrative expenses	593.3		507.6
Income from operations	400.5		349.2
Interest expense, net	60.6		45.4
Other income (expense), net	27.0		0.8
Earnings before income taxes	366.9		304.6
Income taxes	77.9		64.3
Net earnings	$	289.0	$	240.3
Net earnings per share:
Basic	$	2.75	$	2.30
Diluted	$	2.73	$	2.28
Weighted average common shares outstanding:
Basic	105.0		104.3
Diluted	106.0		105.3

See accompanying notes to Condensed Consolidated Financial Statements.

3

Roper Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (unaudited)

(in millions)

	Three months ended March 31,
	2021		2020
Net earnings	$	289.0	$	240.3
Other comprehensive income, net of tax:
Foreign currency translation adjustments	14.6		(128.2)
Total other comprehensive income (loss), net of tax	14.6		(128.2)
Comprehensive income	$	303.6	$	112.1

See accompanying notes to Condensed Consolidated Financial Statements.

4

Roper Technologies, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (unaudited)

(in millions)

	March 31, 2021		December 31, 2020
ASSETS:
Cash and cash equivalents	$	331.0	$	308.3
Accounts receivable, net	792.0		863.0
Inventories, net	206.0		198.4
Income taxes receivable	13.2		21.9
Unbilled receivables	268.0		241.7
Other current assets	129.2		119.0
Total current assets	1,739.4		1,752.3
Property, plant and equipment, net	134.6		140.6
Goodwill	14,405.3		14,395.2
Other intangible assets, net	7,066.8		7,206.9
Deferred taxes	102.3		104.0
Other assets	422.7		425.8
Total assets	$	23,871.1	$	24,024.8
LIABILITIES AND STOCKHOLDERS’ EQUITY:
Accounts payable	$	190.9	$	177.8
Accrued compensation	234.0		286.1
Deferred revenue	1,023.4		994.6
Other accrued liabilities	448.5		457.0
Income taxes payable	64.0		26.9
Current portion of long-term debt, net	502.1		502.0
Total current liabilities	2,462.9		2,444.4
Long-term debt, net of current portion	8,571.8		9,064.5
Deferred taxes	1,571.6		1,562.5
Other liabilities	499.1		473.6
Total liabilities	13,105.4		13,545.0
Commitments and contingencies (Note 8)
Common stock	1.1		1.1
Additional paid-in capital	2,138.9		2,097.5
Retained earnings	8,776.0		8,546.2
Accumulated other comprehensive loss	(132.4)		(147.0)
Treasury stock	(17.9)		(18.0)
Total stockholders’ equity	10,765.7		10,479.8
Total liabilities and stockholders’ equity	$	23,871.1	$	24,024.8

See accompanying notes to Condensed Consolidated Financial Statements.

5

Roper Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (unaudited)

(in millions)

	Three months ended March 31,
	2021		2020
Cash flows from operating activities:
Net earnings	$	289.0	$	240.3
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	14.7		12.8
Amortization of intangible assets	146.6		101.8
Amortization of deferred financing costs	3.4		2.1
Non-cash stock compensation	32.9		27.7
Gain on sale of assets, net of tax	(21.6)		—
Income tax provision, excluding tax associated with gain on sale of assets	72.4		64.3
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	70.3		69.1
Unbilled receivables	(22.2)		(43.1)
Inventories	(8.2)		(10.3)
Accounts payable and accrued liabilities	(46.4)		(70.2)
Deferred revenue	60.5		3.6
Cash income taxes paid	(17.8)		(24.1)
Other, net	(14.0)		(10.1)
Cash provided by operating activities	559.6		363.9
Cash flows from (used in) investing activities:
Acquisitions of businesses, net of cash acquired	—		(2.8)
Capital expenditures	(9.1)		(7.9)
Capitalized software expenditures	(7.2)		(2.6)
Proceeds from (used in) disposal of businesses	(0.1)		(3.7)
Proceeds from sale of assets	27.1		—
Cash provided by (used in) investing activities	10.7		(17.0)
Cash flows from (used in) financing activities:
Borrowings (payments) under revolving line of credit, net	(495.0)		—
Cash dividends to stockholders	(58.8)		(53.1)
Proceeds from stock-based compensation, net	4.4		12.1
Treasury stock sales	4.7		2.8
Other	(0.5)		(0.5)
Cash flows used in financing activities	(545.2)		(38.7)
Effect of foreign currency exchange rate changes on cash	(2.4)		(18.1)
Net increase in cash and cash equivalents	22.7		290.1
Cash and cash equivalents, beginning of period	308.3		709.7
Cash and cash equivalents, end of period	$	331.0	$	999.8

See accompanying notes to Condensed Consolidated Financial Statements.

6

Roper Technologies, Inc. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited)

(in millions)

	Common stock		Additional paid-in capital		Retained earnings		Accumulated other comprehensive loss		Treasury stock		Total stockholders’ equity
Balances at December 31, 2020	$	1.1	$	2,097.5	$	8,546.2	$	(147.0)	$	(18.0)	$	10,479.8
Net earnings	—		—		289.0		—		—		289.0
Stock option exercises	—		19.2		—		—		—		19.2
Treasury stock sold	—		4.6		—		—		0.1		4.7
Currency translation adjustments	—		—		—		14.6		—		14.6
Stock-based compensation	—		32.4		—		—		—		32.4
Restricted stock activity	—		(14.8)		—		—		—		(14.8)
Dividends declared ($0.5625 per share)	—		—		(59.2)		—		—		(59.2)
Balances at March 31, 2021	$	1.1	$	2,138.9	$	8,776.0	$	(132.4)	$	(17.9)	$	10,765.7
Balances at December 31, 2019	$	1.1	$	1,903.9	$	7,818.0	$	(212.8)	$	(18.3)	$	9,491.9
Adoption of ASC 326	—		—		(1.7)		—		—		(1.7)
Net earnings	—		—		240.3		—		—		240.3
Stock option exercises	—		22.9		—		—		—		22.9
Treasury stock sold	—		2.7		—		—		0.1		2.8
Currency translation adjustments	—		—		—		(128.2)		—		(128.2)
Stock-based compensation	—		27.6		—		—		—		27.6
Restricted stock activity	—		(10.8)		—		—		—		(10.8)
Dividends declared ($0.5125 per share)	—		—		(53.5)		—		—		(53.5)
Balances at March 31, 2020	$	1.1	$	1,946.3	$	8,003.1	$	(341.0)	$	(18.2)	$	9,591.3

See accompanying notes to Condensed Consolidated Financial Statements.

7

Roper Technologies, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

All currency and share amounts are in millions, except per share data

1.    Basis of Presentation

The accompanying Condensed Consolidated Financial Statements for the three months ended March 31, 2021 and 2020 are unaudited. In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Technologies, Inc. and its subsidiaries (“Roper,” the “Company,” “we,” “our” or “us”) for all periods presented. The December 31, 2020 financial position data included herein was derived from the audited consolidated financial statements included in the Company’s 2020 Annual Report on Form 10-K (“Annual Report”) filed on February 22, 2021 with the Securities and Exchange Commission (“SEC”) but does not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”).

Roper’s management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these Condensed Consolidated Financial Statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited Condensed Consolidated Financial Statements in conjunction with Roper’s audited consolidated financial statements and the notes thereto included in its Annual Report. Certain prior period amounts have been reclassified to conform to current period presentation.

On March 17, 2021, Roper completed the sale of a minority investment in Sedaru, Inc. for $27.1. The pretax gain on the sale was $27.1, which is reported in Other income/(expense), net in the Condensed Consolidated Statement of Earnings.

2.    Recent Accounting Pronouncements

The Financial Accounting Standards Board FASB (“FASB”) establishes changes to accounting principles under GAAP in the form of accounting standards updates (“ASUs”) to the Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. Any recent ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s results of operations, financial position or cash flows.

Recently Adopted Accounting Pronouncements

The Company adopted ASC Topic 326, Financial Instruments - Credit Losses (“ASC 326”), as of January 1, 2020 using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables, and unbilled receivables. We recorded a noncash cumulative effect decrease to retained earnings of $1.7, net of income taxes, on our opening consolidated balance sheet as of January 1, 2020.

8

3.    Weighted Average Shares Outstanding

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options based upon the trading price of Roper’s common stock. The effects of potential common stock were determined using the treasury stock method. Weighted average shares outstanding are shown below:

	Three months ended March 31,
	2021	2020
Basic shares outstanding	105.0	104.3
Effect of potential common stock:
Common stock awards	1.0	1.0
Diluted shares outstanding	106.0	105.3

For the three months ended March 31, 2021, there were 0.647 outstanding stock options that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 1.318 outstanding stock options that would have been antidilutive in the respective 2020 period.

4.    Stock Based Compensation

The Roper Technologies, Inc. 2016 Incentive Plan (“2016 Plan”) is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper’s employees, officers, directors and consultants.

The following table provides information regarding the Company’s stock-based compensation expense:

	Three Months Ended March 31,
	2021		2020
Stock-based compensation	$	32.9	$	27.7
Tax effect recognized in net earnings	6.9		5.8

Stock Options - In the three months ended March 31, 2021, 0.498 options were granted with a weighted average fair value of $94.69 per option. During the same period in 2020, 0.725 options were granted with a weighted average fair value of $62.02 per option. All options were issued with an exercise price equal to the closing price of Roper’s common stock on the date of grant, as required by the 2016 Plan.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:

	Three months ended March 31,
	2021	2020
Risk-free interest rate (%)	0.94	0.83
Expected option life (years)	5.61	5.64
Expected volatility (%)	25.16	20.18
Expected dividend yield (%)	0.56	0.62

Cash received from option exercises for the three months ended March 31, 2021 and 2020 was $19.2 and $22.9, respectively.

Restricted Stock Grants - During the three months ended March 31, 2021, the Company granted 0.207 shares with a weighted average grant date fair value of $404.14 per restricted share. During the same period in 2020, the Company granted 0.179

9

shares with a weighted average grant date fair value of $340.92 per restricted share. All grants were issued at grant date fair value.

During the three months ended March 31, 2021, 0.116 restricted shares vested with a weighted average grant date fair value of $311.33 per restricted share and a weighted average vest date fair value of $394.23 per restricted share.

Employee Stock Purchase Plan - Roper’s employee stock purchase plan (“ESPP”) previously allowed employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper’s common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. Common stock sold to employees pursuant to the stock purchase plan may be either treasury stock, stock purchased on the open market, or newly issued shares.

We amended the ESPP effective July 1, 2020, which allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper’s common stock at a 10% discount on the lower of the closing price of the stock on the first and last day of each quarterly offering period. Common stock sold to employees pursuant to the ESPP may be either treasury stock, stock purchased on the open market, or newly issued shares.

During the three months ended March 31, 2021 and 2020, participants in the ESPP purchased 0.013 and 0.008 shares of Roper’s common stock for total consideration of $4.7 and $2.8, respectively. All shares were purchased from Roper’s treasury shares.

5.    Inventories

The components of inventory were as follows:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	134.0	$	128.4
Work in process	30.3		28.2
Finished products	83.4		82.2
Inventory reserves	(41.7)		(40.4)
Inventories, net	$	206.0	$	198.4

6.    Goodwill and Other Intangible Assets

The carrying value of goodwill by segment was as follows:

	Application Software		Network Software & Systems		Measurement & Analytical Solutions		Process Technologies		Total
Balances at December 31, 2020	$	8,802.3	$	4,083.1	$	1,190.8	$	319.0	$	14,395.2
Additions	—		—		—		—		—
Other	(4.0)		0.7		—		—		(3.3)
Currency translation adjustments	3.5		10.4		(0.7)		0.2		13.4
Balances at March 31, 2021	$	8,801.8	$	4,094.2	$	1,190.1	$	319.2	$	14,405.3

Other relates primarily to purchase accounting adjustments for acquisitions.

10

Other intangible assets were comprised of:

	Cost		Accumulated amortization		Net book value
Assets subject to amortization:
Customer related intangibles	$	7,494.7	$	(1,703.8)	$	5,790.9
Unpatented technology	942.8		(363.9)		578.9
Software	172.4		(127.4)		45.0
Patents and other protective rights	13.0		(6.7)		6.3
Trade names	7.3		(5.6)		1.7
Assets not subject to amortization:
Trade names	784.1		—		784.1
Balances at December 31, 2020	$	9,414.3	$	(2,207.4)	$	7,206.9
Assets subject to amortization:
Customer related intangibles	$	7,499.6	$	(1,817.2)	$	5,682.4
Unpatented technology	943.3		(392.4)		550.9
Software	172.5		(131.3)		41.2
Patents and other protective rights	13.3		(6.9)		6.4
Trade names	7.3		(5.9)		1.4
Assets not subject to amortization:
Trade names	784.5		—		784.5
Balances at March 31, 2021	$	9,420.5	$	(2,353.7)	$	7,066.8

Amortization expense of other intangible assets was $145.4 and $100.7 during the three months ended March 31, 2021 and 2020, respectively.

An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2021. The Company will perform the annual analysis during the fourth quarter of 2021.

7.    Fair Value of Financial Instruments

Roper’s debt at March 31, 2021 included $8,000 of fixed-rate senior notes with the following fair values:

$500 2.800% senior notes due 2021	508
$500 3.125% senior notes due 2022	518
$300 0.450% senior notes due 2022	300
$700 3.650% senior notes due 2023	750
$500 2.350% senior notes due 2024	523
$300 3.850% senior notes due 2025	332
$700 1.000% senior notes due 2025	689
$700 3.800% senior notes due 2026	778
$700 1.400% senior notes due 2027	677
$800 4.200% senior notes due 2028	902
$700 2.950% senior notes due 2029	730
$600 2.000% senior notes due 2030	574
$1,000 1.750% senior notes due 2031	929

The fair values of the senior notes are based on the trading prices of each series of notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.

11

8.    Contingencies

Roper, in the ordinary course of business, is party to various pending or threatened legal actions, including product liability, intellectual property, data privacy and employment practices that, in general, are of a nature consistent with those over the past several years. After analyzing the Company’s contingent liabilities on a gross basis and, based upon past experience with resolution of such legal claims and the availability and limits of the primary, excess, and umbrella liability insurance coverages with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper’s consolidated financial position, results of operations or cash flows.

Roper’s subsidiary, Vertafore, Inc., has been named in three putative class actions, two in the U.S. District Court for the Southern District of Texas (Allen, et al. v. Vertafore, Inc., Case 4:20-cv-4139, filed December 4, 2020 and Masciotra, et al. v. Vertafore, Inc., originally filed on December 8, 2020 as Case 1:20-cv-03603 in the U.S. District Court for the District of Colorado and subsequently transferred), and one in the U.S. District Court for the Northern District of Texas (Mulvey, et al. v. Vertafore, Inc., Case 3:21-cv-00213-E, filed January 31, 2021). All three cases purport to represent approximately 27.7 million individuals who held Texas driver’s licenses prior to February 2019. In November 2020, Vertafore announced that as a result of human error, three data files were inadvertently stored in an unsecured external storage service that appears to have been accessed without authorization. The files, which included driver information for licenses issued before February 2019, contained Texas driver license numbers, as well as names, dates of birth, addresses and vehicle registration histories. The files did not contain any Social Security numbers or financial account information. The cases each seek recovery under the Driver’s Privacy Protection Act, 18 U.S.C. § 2721. Vertafore is vigorously defending the matters. In addition, Roper has been advised that the Texas Attorney General is investigating the data event.

Roper or its subsidiaries have been named defendants along with numerous industrial companies in asbestos-related litigation claims in certain U.S. states. No significant resources have been required by Roper to respond to these cases and Roper believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims, it is not possible to determine the potential liability, if any.

12

9.    Business Segments

Net revenues and operating profit by segment are set forth in the following table:

	Three months ended March 31,
	2021		2020		Change %
Net revenues:
Application Software	$	576.6	$	405.1	42.3	%
Network Software & Systems	440.2		438.2		0.5	%
Measurement & Analytical Solutions	381.0		365.2		4.3	%
Process Technologies	130.8		142.2		(8.0)	%
Total	$	1,528.6	$	1,350.7	13.2	%
Gross profit:
Application Software	$	398.7	$	270.4	47.4	%
Network Software & Systems	299.4		293.2		2.1	%
Measurement & Analytical Solutions	224.7		214.6		4.7	%
Process Technologies	71.0		78.6		(9.7)	%
Total	$	993.8	$	856.8	16.0	%
Operating profit*:
Application Software	$	153.7	$	97.6	57.5	%
Network Software & Systems	135.5		138.7		(2.3)	%
Measurement & Analytical Solutions	124.1		114.0		8.9	%
Process Technologies	38.3		43.3		(11.5)	%
Total	$	451.6	$	393.6	14.7	%
Long-lived assets:
Application Software	$	126.7	$	85.1	48.9	%
Network Software & Systems	44.8		48.5		(7.6)	%
Measurement & Analytical Solutions	35.4		39.1		(9.5)	%
Process Technologies	19.5		21.0		(7.1)	%
Total	$	226.4	$	193.7	16.9	%

*Segment operating profit is before unallocated corporate general and administrative expenses; these expenses were $51.1 and $44.4 for the three months ended March 31, 2021 and 2020, respectively.

10.    Revenues from Contracts

Disaggregated Revenue - We disaggregate our revenues into two categories: (i) software and related services; and (ii) engineered products and related services. Software and related services revenues are primarily derived from our Application Software and Network Software & Systems reportable segments. Engineered products and related services revenues are derived from all of our reportable segments except Application Software and comprise substantially all of the revenues generated in our Measurement & Analytical Solutions and Process Technologies reportable segments. See details in the table below.

	Three Months Ended March 31,
	2021		2020
Software and related services	$	864.5	$	668.5
Engineered products and related services	664.1		682.2
Net revenues	$	1,528.6	$	1,350.7

Remaining performance obligations - Remaining performance obligations represent the transaction price of firm orders for which work has not been performed and excludes unexercised contract options. As of March 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $4,102.4. We expect to recognize revenue on

13

approximately 63% of our remaining performance obligations over the next 12 months (“Backlog”), with the remainder to be recognized thereafter.

Contract balances

Balance Sheet Account	March 31, 2021		December 31, 2020		Change
Unbilled receivables	$	268.0	$	241.7	$	26.3
Contract liabilities - current (1)	(1,036.9)		(1,012.0)		(24.9)
Deferred revenue - non-current (2)	(76.4)		(43.1)		(33.3)
Net contract assets/(liabilities)	$	(845.3)	$	(813.4)	$	(31.9)

(1) Consists of “Deferred revenue,” and billings in-excess of revenues (“BIE”). BIE is reported in “Other accrued liabilities” in our Condensed Consolidated Balance Sheets.

(2) The non-current portion of deferred revenue is included in “Other liabilities” in our Condensed Consolidated Balance Sheets.

The change in our net contract assets/(liabilities) from December 31, 2020 to March 31, 2021 was due primarily to the timing of payments and invoicing relating to Software-as-a-Service (“SaaS”) and post contract support (“PCS”) renewals, partially offset by the increase in unbilled receivables associated with timing of invoicing in our project-based businesses, most notably our Transcore business.

Most of the Company’s project-based contracts where the input method of revenue recognition is utilized are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Often this results in billing occurring after revenue recognition resulting in contract assets. The Company records contract liabilities when cash payments are received or due in advance of the Company’s performance relating primarily to SaaS and PCS renewals. Revenue recognized during the three months ended March 31, 2021 and 2020 that was included in the contract liability balance on December 31, 2020 and 2019 was $459.1 and $323.5, respectively.

In order to determine revenues recognized in the period from contract liabilities, we allocate revenue to the individual deferred revenue or billings in-excess of revenues balance outstanding at the beginning of the year until the revenue exceeds that balance.

Impairment losses recognized on our accounts receivable and unbilled receivables were immaterial in the three months ended March 31, 2021.

14

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2020 (“Annual Report”) as filed on February 22, 2021 with the U.S. Securities and Exchange Commission (“SEC”) and the Notes to Condensed Consolidated Financial Statements included elsewhere in this report.

Information About Forward-Looking Statements

This report includes “forward-looking statements” within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the U.S. Securities and Exchange Commission (“SEC”) or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are “forward-looking statements.” Forward-looking statements may be indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “believes” or “intends” and similar words and phrases. These statements reflect management’s current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement. Such risks and uncertainties include the effects of the COVID-19 pandemic on our business, operations, financial results and liquidity, including the duration and magnitude of such effects, which will depend on numerous evolving factors that we cannot accurately predict or assess, including: the duration and scope of the pandemic generally and in the geographical markets that we serve or in which we operate; the negative impact on global and regional markets, economies and economic activity; actions governments, businesses and individuals take in response to the pandemic; the effects of the pandemic, including all of the foregoing, on our employees, customers, suppliers, and business partners, and how quickly economies and demand for our products and services recover following the pandemic.

Additional examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our operating plans, our expectations regarding our ability to generate cash and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, demand for our products, the cost, timing and success of product upgrades and new product introductions, raw material costs, expected pricing levels, expected outcomes of pending litigation, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:

•general economic conditions;

•difficulty making acquisitions and successfully integrating acquired businesses;

•any unforeseen liabilities associated with future acquisitions;

•limitations on our business imposed by our indebtedness;

•unfavorable changes in foreign exchange rates;

•failure to effectively mitigate cybersecurity threats, including any litigation arising therefrom;

•failure to comply with new data privacy laws and regulations, including any litigation arising therefrom;

•difficulties associated with exports/imports and risks of changes to tariff rates;

•risks and costs associated with our international sales and operations;

•rising interest rates;

•product liability and insurance risks;

•increased warranty exposure;

•future competition;

•the cyclical nature of some of our markets;

•reduction of business with large customers;

•risks associated with government contracts;

•changes in the supply of, or price for, raw materials, parts and components;

•environmental compliance costs and liabilities;

•risks and costs associated with asbestos-related litigation;

•potential write-offs of our goodwill and other intangible assets;

•our ability to successfully develop new products;

•failure to protect our intellectual property;

•the effect of, or change in, government regulations (including tax);

15

•economic disruption caused by terrorist attacks, health crises (such as the COVID-19 pandemic) or other unforeseen geopolitical events; and

•the factors discussed in other reports filed with the SEC from time to time.

We believe these forward-looking statements are reasonable. However, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of them in light of new information or future events.

Overview

Roper Technologies, Inc. (“Roper,” “we,” “us” or “our”) is a diversified technology company. We operate businesses that design and develop software (both license and SaaS) and engineered products and solutions for a variety of niche end markets.

We pursue consistent and sustainable growth in earnings and cash flow by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other businesses that offer high value-added software, services, engineered products and solutions that we believe are capable of achieving growth and maintaining high margins. We compete in many niche markets and believe we are the market leader or a competitive alternative to the market leader in most of these markets.

Critical Accounting Policies

There were no material changes during the three months ended March 31, 2021 to the items that we disclosed as our critical accounting policies and estimates in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report.

Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the Notes to Condensed Consolidated Financial Statements.  

Impact of COVID-19 on our Business

Our top priority during the coronavirus (COVID-19) pandemic is the health and safety of our employees, customers and vendors. The leadership teams at our businesses continue to be proactive in instituting safety measures that protect our employees, customers and vendors, while maintaining operational capabilities required to meet our customers’ needs. All our businesses with manufacturing facilities have been deemed essential businesses and remain operational, supplying our customers with critical products. Additionally, all of our businesses continue to be operational in their work-from-home environments with limited disruption.

The spread of COVID-19 has caused us to modify our business practices, and we may take further actions as required by governmental and other regulatory authorities or as we determine to protect the safety or best interests of our employees, customers, suppliers and business partners. Some changes in business practices include, but are not limited to: restricting employee travel, developing social distancing plans for our employees, expanding the number of our associates who work from home, and cancelling physical participation in meetings, events and conferences.

The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus and its variants including distribution and administration of available vaccines, and how quickly and to what extent normal economic and operating conditions can resume. As COVID-19 and its variants spread, particularly in countries with low vaccination rates, certain countries may experience more severe and lasting impacts from the pandemic. To the extent we have operations and/or customers in these countries, we may experience adverse impacts on our businesses located in such countries. For example, India is currently experiencing a severe outbreak of COVID-19. While most of our employees located in India are currently able to continue to operate in work-from-home environments, to the extent the outbreak intensifies or persists indefinitely it is difficult to predict how such outbreak may ultimately impact our businesses with employees and/or operations located in India.

16

Results of Operations

All currency amounts are in millions, percentages are of net revenues

General

Percentages may not sum due to rounding.

The following table sets forth selected information for the periods indicated.

	Three months ended March 31,
	2021			2020
Net revenues:
Application Software	$	576.6		$	405.1
Network Software & Systems	440.2			438.2
Measurement & Analytical Solutions	381.0			365.2
Process Technologies	130.8			142.2
Total	$	1,528.6		$	1,350.7
Gross margin:
Application Software	69.1		%	66.7		%
Network Software & Systems	68.0			66.9
Measurement & Analytical Solutions	59.0			58.8
Process Technologies	54.3			55.3
Total	65.0			63.4
Selling, general and administrative expenses:
Application Software	42.5		%	42.7		%
Network Software & Systems	37.2			35.3
Measurement & Analytical Solutions	26.4			27.5
Process Technologies	25.0			24.8
Total	35.5			34.3
Segment operating margin:
Application Software	26.7		%	24.1		%
Network Software & Systems	30.8			31.7
Measurement & Analytical Solutions	32.6			31.2
Process Technologies	29.3			30.5
Total	29.5			29.1
Corporate administrative expenses	(3.3)			(3.3)
Income from operations	26.2			25.9
Interest expense, net	(4.0)			(3.4)
Other income (expense), net	1.8			0.1
Earnings before income taxes	24.0			22.6
Income taxes	(5.1)			(4.8)
Net earnings	18.9		%	17.8		%

Three months ended March 31, 2021 compared to three months ended March 31, 2020

Net revenues for the three months ended March 31, 2021 increased by 13% as compared to the three months ended March 31, 2020. The increase was the result of net acquisition/divestiture contribution of 12% and a foreign exchange benefit of 1%, partially offset by an organic decline of 1%.

17

In our Application Software segment, revenues were $576.6 in the first quarter of 2021 as compared to $405.1 in the first quarter of 2020, an increase of 42%. Acquisitions contributed 38%, organic revenues increased 2% and foreign exchange contributed 1% to growth in the segment. The increase in organic revenues was due primarily to our businesses serving the healthcare and government contracting markets, partially offset by declines in our businesses serving the education markets. Gross margin increased to 69.1% in the first quarter of 2021 as compared to 66.7% in the first quarter of 2020 due primarily to the acquisition of Vertafore and favorable revenue mix across the segment. Selling, general and administrative (“SG&A”) expenses as a percentage of revenues decreased to 42.5% in the first quarter of 2021 as compared to 42.7% in the first quarter of 2020 due primarily to operating leverage on organic revenue growth, partially offset by higher amortization of acquired intangibles from the Vertafore and EPSi acquisitions. The resulting operating margin was 26.7% in the first quarter of 2021 as compared to 24.1% in the first quarter of 2020.

In our Network Software & Systems segment, revenues were relatively flat at $440.2 in the first quarter of 2021 as compared to $438.2 in the first quarter of 2020. Organic revenues decreased 2%, offset by growth in the segment due to contributions from acquisitions of 2% and foreign exchange of 1%. The decrease in organic revenues was primarily due to project timing and lower toll tag volumes in our toll and traffic business, partially offset by subscription growth at our SaaS businesses. Gross margin increased to 68.0% in the first quarter of 2021 as compared to 66.9% in the first quarter of 2020 due primarily to revenue mix. SG&A expenses as a percentage of revenues increased to 37.2% in the first quarter of 2021 as compared to 35.3% in the first quarter of 2020 due primarily to revenue mix. As a result, operating margin was 30.8% in the first quarter of 2021 as compared to 31.7% in the first quarter of 2020.

Our Measurement & Analytical Solutions segment revenues increased by 4% to $381.0 in the first quarter of 2021 as compared to $365.2 in the first quarter of 2020. Organic revenues increased 2% and foreign exchange contributed 2% to growth in the segment. The growth in organic revenues was primarily due to our medical products businesses, partially offset by declines in our water meter technology business, due to restricted access to indoor meters located in the Northeast United States and Canada. Gross margin increased to 59.0% in the first quarter of 2021 as compared to 58.8% in the first quarter of 2020 due primarily to revenue mix. SG&A expenses as a percentage of revenues decreased to 26.4% in the first quarter of 2021 as compared to 27.5% in the first quarter of 2020 due primarily to higher operating leverage on organic revenue growth. The resulting operating margin was 32.6% in the first quarter of 2021 as compared to 31.2% in the first quarter of 2020.

Our Process Technologies segment revenues decreased by 8% to $130.8 in the first quarter of 2021 as compared to $142.2 in the first quarter of 2020. Organic revenues decreased 10%, partially offset by a foreign exchange contribution of 2%. Organic revenues decreased due to broad-based revenue declines across the segment led by lower demand at our businesses serving upstream oil and gas end markets. Gross margin decreased to 54.3% in the first quarter of 2021 as compared to 55.3% in the first quarter of 2020 due primarily to lower revenues across the businesses. SG&A expenses as a percentage of revenues increased to 25.0% in the first quarter of 2021 as compared to 24.8% in the first quarter of 2020 due primarily to lower operating leverage on organic revenue declines. As a result, operating margin was 29.3% in the first quarter of 2021 as compared to 30.5% in the first quarter of 2020.

Corporate expenses increased to $51.1, or 3.3% of revenues, in the first quarter of 2021 as compared to $44.4, or 3.3% of revenues, in the first quarter of 2020. The dollar increase was due primarily to higher compensation related expenses, partially offset by lower acquisition related expenses.

Net interest expense was $60.6 for the first quarter of 2021 as compared to $45.4 for the first quarter of 2020 due to higher weighted average debt balances, partially offset by lower weighted average interest rates.

Other income, net, of $27.0 for the first quarter of 2021 was composed primarily of a gain on sale of minority investment of $27.1. Other income, net, of $0.8 for the first quarter of 2020 was composed primarily of foreign exchange gains at our non-U.S. based subsidiaries

Income taxes as a percent of pretax earnings were relatively flat at 21.2% in the first quarter of 2021 as compared to 21.1% in the first quarter of 2020.

Backlog is equal to our remaining performance obligations expected to be recognized within the next 12 months as discussed in Note 10 of the Notes to Condensed Consolidated Financial Statements. Backlog increased 25% to $2,578.7 at March 31, 2021 as compared to $2,070.3 at March 31, 2020, organic growth was 3% and acquisitions contributed 22%.

18

	Backlog as of
	March 31,
	2021		2020
Application Software	$	1,394.6	$	838.6
Network Software & Systems	814.4		877.9
Measurement & Analytical Solutions	252.8		236.3
Process Technologies	116.9		117.5
Total	$	2,578.7	$	2,070.3

Financial Condition, Liquidity and Capital Resources

All currency amounts are in millions

Selected cash flows for the three months ended March 31, 2021 and 2020 were as follows:

	Three months ended March 31,
Cash provided by/(used in):	2021		2020
Operating activities	$	559.6	$	363.9
Investing activities	10.7		(17.0)
Financing activities	(545.2)		(38.7)

Operating activities - Net cash provided by operating activities increased by 54% to $559.6 in the three months ended March 31, 2021 as compared to $363.9 in the three months ended March 31, 2020, due primarily to higher net income net of non-cash expenses and growth in our software businesses, which generated cash from working capital in the quarter. Additionally, wins at our UK-based laboratory software business generated approximately $36 of accelerated cash payments in the quarter.

Investing activities - Cash provided by investing activities during the three months ended March 31, 2021 is due primarily to the proceeds from the sale of a minority investment, partially offset by capital expenditures. Cash used in investing activities during the three months ended March 31, 2020 was primarily for capital expenditures.

Financing activities - Cash used in financing activities for the three months ended March 31, 2021 was primarily due to net repayments on our unsecured credit facility and dividend payments. Cash used in financing activities during the three months ended March 31, 2020 was primarily due to dividend payments, partially offset by net proceeds from stock-based compensation.

Effect of foreign currency exchange rate changes on cash - Cash and cash equivalents decreased during the three months ended March 31, 2021 by $2.4 due primarily to the strengthening of the U.S. dollar against the functional currencies of our European subsidiaries. Cash and cash equivalents decreased during the three months ended March 31, 2020 by $18.1 due primarily to the strengthening of the U.S. dollar against the functional currencies of our United Kingdom, European and Canadian subsidiaries.

19

Total debt at March 31, 2021 consisted of the following:

$500 2.800% senior notes due 2021	500.0
$500 3.125% senior notes due 2022	500.0
$300 0.450% senior notes due 2022	300.0
$700 3.650% senior notes due 2023	700.0
$500 2.350% senior notes due 2024	500.0
$300 3.850% senior notes due 2025	300.0
$700 1.000% senior notes due 2025	700.0
$700 3.800% senior notes due 2026	700.0
$700 1.400% senior notes due 2027	700.0
$800 4.200% senior notes due 2028	800.0
$700 2.950% senior notes due 2029	700.0
$600 2.000% senior notes due 2030	600.0
$1,000 1.750% senior notes due 2031	1,000.0
Unsecured credit facility	1,125.0
Deferred finance costs	(56.8)
Other	5.7
Total debt, net of deferred finance costs	9,073.9
Less current portion	502.1
Long-term debt, net of deferred finance costs	$	8,571.8

The interest rate on borrowings under our $3,000.0 unsecured credit facility is calculated based upon various recognized indices plus a margin as defined in the credit facility. At March 31, 2021, there were $1,125.0 outstanding borrowings under our unsecured credit facility. At March 31, 2021, we had $5.7 of other debt in the form of short term borrowings, finance leases and several smaller facilities that allow for borrowings in various foreign locations to support our non-U.S. businesses and $67.1 of outstanding letters of credit.

Cash at our foreign subsidiaries at March 31, 2021 increased to $296 as compared to $259 at December 31, 2020 due primarily to the cash generated at our foreign subsidiaries during the three months ended March 31, 2021, partially offset by the repatriation of $107 during the quarter. We intend to repatriate substantially all historical and future earnings.

We expect existing cash balances, together with cash generated by our operations and amounts available under our credit facility, will be sufficient to fund our operating requirements for the foreseeable future.

We were in compliance with all debt covenants related to our unsecured credit facility throughout the three months ended March 31, 2021.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was negative $552.4 at March 31, 2021 as compared to negative $498.4 at December 31, 2020, reflecting a decrease in working capital due primarily to a decrease in accounts receivable, net and an increase in income taxes payable, partially offset by a decrease in accrued compensation resulting from the timing of payments. Consistent negative net working capital demonstrates Roper’s continued evolution and focus on asset-light business models. Total debt was $9,073.9 at March 31, 2021 as compared to $9,566.5 at December 31, 2020, due primarily to the net repayments under our unsecured credit facility. Our leverage is shown in the following table:

20

	March 31, 2021			December 31, 2020
Total debt	$	9,073.9		$	9,566.5
Cash	(331.0)			(308.3)
Net debt	8,742.9			9,258.2
Stockholders’ equity	10,765.7			10,479.8
Total net capital	$	19,508.6		$	19,738.0
Net debt / total net capital	44.8		%	46.9		%

Capital expenditures were $9.1 for the three months ended March 31, 2021 as compared to $7.9 for the three months ended March 31, 2020. Capitalized software expenditures were $7.2 for the three months ended March 31, 2021 as compared to $2.6 for the three months ended March 31, 2020. We expect the aggregate of capital expenditures and capitalized software expenditures for the balance of the year to be comparable to prior years as a percentage of revenues.

Off-Balance Sheet Arrangements

At March 31, 2021, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Outlook

Current geopolitical and economic uncertainties could adversely affect our business prospects. The COVID-19 pandemic has had, and may continue to have, an adverse impact on our business. A significant terrorist attack, other global conflict, or public health crisis could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these potential factor’s future effects on current economic conditions or any of our businesses. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also would similarly disrupt the economy and have an adverse impact on our businesses.

Although we maintain an active acquisition program we are currently focused on reducing debt. Future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, future divestitures, the proceeds from the issuance of new debt or equity securities or any combination of these methods, the terms and availability of which will be subject to market and economic conditions generally.

We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt in accordance with the repayment schedule. However, the rate at which we can reduce our debt during 2021 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions, the financial performance of our existing companies and the impact of the COVID-19 pandemic on our business prospects and the financial markets generally. None of these factors can be predicted with certainty.

21

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See “Item 7A. Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report. There were no material changes during the three months ended March 31, 2021.

ITEM 4.    CONTROLS AND PROCEDURES

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q (“Evaluation Date”). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal controls during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

22

PART II.    OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

Information pertaining to legal proceedings can be found in Note 8 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q and is incorporated by reference herein.

ITEM 1A.    RISK FACTORS

Information regarding risk factors can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Information About Forward-Looking Statements,” in Part 1 - Item 2 of this Form 10-Q and in Part 1 - Item 1A of our 2020 Annual Report on Form 10-K. There were no material changes during the quarter ended March 31, 2021 to the risk factors reported in the Company’s 2020 Annual Report on Form 10-K.

23

ITEM 6.                  EXHIBITS

31.1	Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
31.2	Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
32.1	Section 1350 Certification of the Chief Executive and Chief Financial Officers, furnished herewith.
101.INS	XBRL Instance Document.
101.SCH	XBRL Taxonomy Extension Schema Document.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

24

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Roper Technologies, Inc.

/S/ L. Neil Hunn	President and Chief Executive Officer	May 5, 2021
L. Neil Hunn	(Principal Executive Officer)

/S/ Robert C. Crisci	Executive Vice President and Chief Financial Officer	May 5, 2021
Robert C. Crisci	(Principal Financial Officer)

/S/ Jason Conley	Vice President and Chief Accounting Officer	May 5, 2021
Jason Conley	(Principal Accounting Officer)

25

EX-31.1

Exhibit 31.1

I, L. Neil Hunn, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Roper Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter  (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2021	/S/ L. Neil Hunn
	L. Neil Hunn
	President and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

I, Robert C. Crisci, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Roper Technologies, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter  (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2021	/S/ Robert C. Crisci
	Robert C. Crisci
	Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Roper Technologies, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), L. Neil Hunn, Chief Executive Officer of the Company, and Robert C. Crisci, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 5, 2021	/S/ L. Neil Hunn
	L. Neil Hunn
	President and Chief Executive Officer
	(Principal Executive Officer)
	/S/ Robert C. Crisci
	Robert C. Crisci
	Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)

This certification accompanies the Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that Roper Technologies, Inc. specifically incorporates it by reference.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2021	Apr. 30, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	1-12273
Entity Registrant Name	ROPER TECHNOLOGIES, INC.
Entity Central Index Key	0000882835
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0263969
Entity Address, Address Line One	6901 Professional Pkwy., Suite 200
Entity Address, City or Town	Sarasota,
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	34240
City Area Code	941
Local Phone Number	556-2601
Title of 12(b) Security	Common Stock, $0.01 Par Value
Trading Symbol	ROP
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		105,239,028

XML

Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Net revenues	$ 1,528.6	$ 1,350.7
Cost of sales	534.8	493.9
Gross profit	993.8	856.8
Selling, general and administrative expenses	593.3	507.6
Income from operations	400.5	349.2
Interest expense, net	60.6	45.4
Other income (expense), net	27.0	0.8
Earnings before income taxes	366.9	304.6
Income taxes	77.9	64.3
Net earnings	$ 289.0	$ 240.3
Net earnings per share:
Basic (in dollars per share)	$ 2.75	$ 2.30
Diluted (in dollars per share)	$ 2.73	$ 2.28
Weighted average common shares outstanding:
Basic (in shares)	105.0	104.3
Diluted (in shares)	106.0	105.3

XML

Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net earnings	$ 289.0	$ 240.3
Other comprehensive income, net of tax:
Foreign currency translation adjustments	14.6	(128.2)
Total other comprehensive income (loss), net of tax	14.6	(128.2)
Comprehensive income	$ 303.6	$ 112.1

XML

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
ASSETS:
Cash and cash equivalents	$ 331.0	$ 308.3
Accounts receivable, net	792.0	863.0
Inventories, net	206.0	198.4
Income taxes receivable	13.2	21.9
Unbilled receivables	268.0	241.7
Other current assets	129.2	119.0
Total current assets	1,739.4	1,752.3
Property, plant and equipment, net	134.6	140.6
Goodwill	14,405.3	14,395.2
Other intangible assets, net	7,066.8	7,206.9
Deferred taxes	102.3	104.0
Other assets	422.7	425.8
Total assets	23,871.1	24,024.8
LIABILITIES AND STOCKHOLDERS’ EQUITY:
Accounts payable	190.9	177.8
Accrued compensation	234.0	286.1
Deferred revenue	1,023.4	994.6
Other accrued liabilities	448.5	457.0
Income taxes payable	64.0	26.9
Current portion of long-term debt, net	502.1	502.0
Total current liabilities	2,462.9	2,444.4
Long-term debt, net of current portion	8,571.8	9,064.5
Deferred taxes	1,571.6	1,562.5
Other liabilities	499.1	473.6
Total liabilities	13,105.4	13,545.0
Commitments and contingencies (Note 8)
Common stock	1.1	1.1
Additional paid-in capital	2,138.9	2,097.5
Retained earnings	8,776.0	8,546.2
Accumulated other comprehensive loss	(132.4)	(147.0)
Treasury stock	(17.9)	(18.0)
Total stockholders’ equity	10,765.7	10,479.8
Total liabilities and stockholders’ equity	$ 23,871.1	$ 24,024.8

XML

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net earnings	$ 289.0	$ 240.3
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	14.7	12.8
Amortization of intangible assets	146.6	101.8
Amortization of deferred financing costs	3.4	2.1
Non-cash stock compensation	32.9	27.7
Gain on sale of assets, net of tax	(21.6)	0.0
Income tax provision, excluding tax associated with gain on sale of assets	72.4	64.3
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	70.3	69.1
Unbilled receivables	(22.2)	(43.1)
Inventories	(8.2)	(10.3)
Accounts payable and accrued liabilities	(46.4)	(70.2)
Deferred revenue	60.5	3.6
Cash income taxes paid	(17.8)	(24.1)
Other, net	(14.0)	(10.1)
Cash provided by operating activities	559.6	363.9
Cash flows from (used in) investing activities:
Acquisitions of businesses, net of cash acquired	0.0	(2.8)
Capital expenditures	(9.1)	(7.9)
Capitalized software expenditures	(7.2)	(2.6)
Proceeds from (used in) disposal of businesses	(0.1)	(3.7)
Proceeds from sale of assets	27.1	0.0
Cash provided by (used in) investing activities	10.7	(17.0)
Cash flows from (used in) financing activities:
Borrowings (payments) under revolving line of credit, net	(495.0)	0.0
Cash dividends to stockholders	(58.8)	(53.1)
Proceeds from stock-based compensation, net	4.4	12.1
Treasury stock sales	4.7	2.8
Other	(0.5)	(0.5)
Cash flows used in financing activities	(545.2)	(38.7)
Effect of foreign currency exchange rate changes on cash	(2.4)	(18.1)
Net increase in cash and cash equivalents	22.7	290.1
Cash and cash equivalents, beginning of period	308.3	709.7
Cash and cash equivalents, end of period	$ 331.0	$ 999.8

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($) $ in Millions	Total	Cumulative Effect, Period Of Adoption, Adjustment	Common stock	Additional paid-in capital	Retained earnings	Retained earnings Cumulative Effect, Period Of Adoption, Adjustment	Accumulated other comprehensive loss	Treasury stock
Balance at Dec. 31, 2019	$ 9,491.9	$ (1.7)	$ 1.1	$ 1,903.9	$ 7,818.0	$ (1.7)	$ (212.8)	$ (18.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	240.3				240.3
Stock option exercises	22.9			22.9
Treasury stock sold	2.8			2.7				0.1
Currency translation adjustments	(128.2)						(128.2)
Stock-based compensation	27.6			27.6
Restricted stock activity	(10.8)			(10.8)
Dividends declared	(53.5)				(53.5)
Balance at Mar. 31, 2020	9,591.3		1.1	1,946.3	8,003.1		(341.0)	(18.2)
Balance at Dec. 31, 2020	10,479.8		1.1	2,097.5	8,546.2	$ (1.7)	(147.0)	(18.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	289.0				289.0
Stock option exercises	19.2			19.2
Treasury stock sold	4.7			4.6				0.1
Currency translation adjustments	14.6						14.6
Stock-based compensation	32.4			32.4
Restricted stock activity	(14.8)			(14.8)
Dividends declared	(59.2)				(59.2)
Balance at Mar. 31, 2021	$ 10,765.7		$ 1.1	$ 2,138.9	$ 8,776.0		$ (132.4)	$ (17.9)

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Stockholders' Equity [Abstract]
Dividends declared (in usd per share)	$ 0.5625	$ 0.5125

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying Condensed Consolidated Financial Statements for the three months ended March 31, 2021 and 2020 are unaudited. In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Technologies, Inc. and its subsidiaries (“Roper,” the “Company,” “we,” “our” or “us”) for all periods presented. The December 31, 2020 financial position data included herein was derived from the audited consolidated financial statements included in the Company’s 2020 Annual Report on Form 10-K (“Annual Report”) filed on February 22, 2021 with the Securities and Exchange Commission (“SEC”) but does not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”).

Roper’s management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these Condensed Consolidated Financial Statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited Condensed Consolidated Financial Statements in conjunction with Roper’s audited consolidated financial statements and the notes thereto included in its Annual Report. Certain prior period amounts have been reclassified to conform to current period presentation.

On March 17, 2021, Roper completed the sale of a minority investment in Sedaru, Inc. for $27.1. The pretax gain on the sale was $27.1, which is reported in Other income/(expense), net in the Condensed Consolidated Statement of Earnings.

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2021

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Financial Accounting Standards Board FASB (“FASB”) establishes changes to accounting principles under GAAP in the form of accounting standards updates (“ASUs”) to the Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. Any recent ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s results of operations, financial position or cash flows.

Recently Adopted Accounting Pronouncements

The Company adopted ASC Topic 326, Financial Instruments - Credit Losses (“ASC 326”), as of January 1, 2020 using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables, and unbilled receivables. We recorded a noncash cumulative effect decrease to retained earnings of $1.7, net of income taxes, on our opening consolidated balance sheet as of January 1, 2020.

XML

Weighted Average Shares Outstanding

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Weighted Average Shares Outstanding

Weighted Average Shares Outstanding

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options based upon the trading price of Roper’s common stock. The effects of potential common stock were determined using the treasury stock method. Weighted average shares outstanding are shown below:

	Three months ended March 31,
	2021	2020
Basic shares outstanding	105.0	104.3
Effect of potential common stock:
Common stock awards	1.0	1.0
Diluted shares outstanding	106.0	105.3

For the three months ended March 31, 2021, there were 0.647 outstanding stock options that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 1.318 outstanding stock options that would have been antidilutive in the respective 2020 period.

XML

Stock Based Compensation

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Stock Based Compensation

Stock Based Compensation

The Roper Technologies, Inc. 2016 Incentive Plan (“2016 Plan”) is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper’s employees, officers, directors and consultants.

The following table provides information regarding the Company’s stock-based compensation expense:

	Three Months Ended March 31,
	2021		2020
Stock-based compensation	$	32.9	$	27.7
Tax effect recognized in net earnings	6.9		5.8

Stock Options - In the three months ended March 31, 2021, 0.498 options were granted with a weighted average fair value of $94.69 per option. During the same period in 2020, 0.725 options were granted with a weighted average fair value of $62.02 per option. All options were issued with an exercise price equal to the closing price of Roper’s common stock on the date of grant, as required by the 2016 Plan.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:

	Three months ended March 31,
	2021	2020
Risk-free interest rate (%)	0.94	0.83
Expected option life (years)	5.61	5.64
Expected volatility (%)	25.16	20.18
Expected dividend yield (%)	0.56	0.62

Cash received from option exercises for the three months ended March 31, 2021 and 2020 was $19.2 and $22.9, respectively.

Restricted Stock Grants - During the three months ended March 31, 2021, the Company granted 0.207 shares with a weighted average grant date fair value of $404.14 per restricted share. During the same period in 2020, the Company granted 0.179

shares with a weighted average grant date fair value of $340.92 per restricted share. All grants were issued at grant date fair value.

During the three months ended March 31, 2021, 0.116 restricted shares vested with a weighted average grant date fair value of $311.33 per restricted share and a weighted average vest date fair value of $394.23 per restricted share.

Employee Stock Purchase Plan - Roper’s employee stock purchase plan (“ESPP”) previously allowed employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper’s common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. Common stock sold to employees pursuant to the stock purchase plan may be either treasury stock, stock purchased on the open market, or newly issued shares.

We amended the ESPP effective July 1, 2020, which allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper’s common stock at a 10% discount on the lower of the closing price of the stock on the first and last day of each quarterly offering period. Common stock sold to employees pursuant to the ESPP may be either treasury stock, stock purchased on the open market, or newly issued shares.

During the three months ended March 31, 2021 and 2020, participants in the ESPP purchased 0.013 and 0.008 shares of Roper’s common stock for total consideration of $4.7 and $2.8, respectively. All shares were purchased from Roper’s treasury shares.

XML

Inventories

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories

The components of inventory were as follows:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	134.0	$	128.4
Work in process	30.3		28.2
Finished products	83.4		82.2
Inventory reserves	(41.7)		(40.4)
Inventories, net	$	206.0	$	198.4

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

The carrying value of goodwill by segment was as follows:

	Application Software		Network Software & Systems		Measurement & Analytical Solutions		Process Technologies		Total
Balances at December 31, 2020	$	8,802.3	$	4,083.1	$	1,190.8	$	319.0	$	14,395.2
Additions	—		—		—		—		—
Other	(4.0)		0.7		—		—		(3.3)
Currency translation adjustments	3.5		10.4		(0.7)		0.2		13.4
Balances at March 31, 2021	$	8,801.8	$	4,094.2	$	1,190.1	$	319.2	$	14,405.3

Other relates primarily to purchase accounting adjustments for acquisitions.

Other intangible assets were comprised of:

	Cost		Accumulated amortization		Net book value
Assets subject to amortization:
Customer related intangibles	$	7,494.7	$	(1,703.8)	$	5,790.9
Unpatented technology	942.8		(363.9)		578.9
Software	172.4		(127.4)		45.0
Patents and other protective rights	13.0		(6.7)		6.3
Trade names	7.3		(5.6)		1.7
Assets not subject to amortization:
Trade names	784.1		—		784.1
Balances at December 31, 2020	$	9,414.3	$	(2,207.4)	$	7,206.9
Assets subject to amortization:
Customer related intangibles	$	7,499.6	$	(1,817.2)	$	5,682.4
Unpatented technology	943.3		(392.4)		550.9
Software	172.5		(131.3)		41.2
Patents and other protective rights	13.3		(6.9)		6.4
Trade names	7.3		(5.9)		1.4
Assets not subject to amortization:
Trade names	784.5		—		784.5
Balances at March 31, 2021	$	9,420.5	$	(2,353.7)	$	7,066.8

Amortization expense of other intangible assets was $145.4 and $100.7 during the three months ended March 31, 2021 and 2020, respectively.

An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2021. The Company will perform the annual analysis during the fourth quarter of 2021.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Roper’s debt at March 31, 2021 included $8,000 of fixed-rate senior notes with the following fair values:

$500 2.800% senior notes due 2021	508
$500 3.125% senior notes due 2022	518
$300 0.450% senior notes due 2022	300
$700 3.650% senior notes due 2023	750
$500 2.350% senior notes due 2024	523
$300 3.850% senior notes due 2025	332
$700 1.000% senior notes due 2025	689
$700 3.800% senior notes due 2026	778
$700 1.400% senior notes due 2027	677
$800 4.200% senior notes due 2028	902
$700 2.950% senior notes due 2029	730
$600 2.000% senior notes due 2030	574
$1,000 1.750% senior notes due 2031	929

The fair values of the senior notes are based on the trading prices of each series of notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.

XML

Contingencies	3 Months Ended
	Mar. 31, 2021
Loss Contingency [Abstract]
Contingencies	Contingencies

XML

Business Segments

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Business Segments

Business Segments

Net revenues and operating profit by segment are set forth in the following table:

	Three months ended March 31,
	2021		2020		Change %
Net revenues:
Application Software	$	576.6	$	405.1	42.3	%
Network Software & Systems	440.2		438.2		0.5	%
Measurement & Analytical Solutions	381.0		365.2		4.3	%
Process Technologies	130.8		142.2		(8.0)	%
Total	$	1,528.6	$	1,350.7	13.2	%
Gross profit:
Application Software	$	398.7	$	270.4	47.4	%
Network Software & Systems	299.4		293.2		2.1	%
Measurement & Analytical Solutions	224.7		214.6		4.7	%
Process Technologies	71.0		78.6		(9.7)	%
Total	$	993.8	$	856.8	16.0	%
Operating profit*:
Application Software	$	153.7	$	97.6	57.5	%
Network Software & Systems	135.5		138.7		(2.3)	%
Measurement & Analytical Solutions	124.1		114.0		8.9	%
Process Technologies	38.3		43.3		(11.5)	%
Total	$	451.6	$	393.6	14.7	%
Long-lived assets:
Application Software	$	126.7	$	85.1	48.9	%
Network Software & Systems	44.8		48.5		(7.6)	%
Measurement & Analytical Solutions	35.4		39.1		(9.5)	%
Process Technologies	19.5		21.0		(7.1)	%
Total	$	226.4	$	193.7	16.9	%

*Segment operating profit is before unallocated corporate general and administrative expenses; these expenses were $51.1 and $44.4 for the three months ended March 31, 2021 and 2020, respectively.

XML

Revenues from Contracts

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenues from Contracts

Revenues from Contracts

Disaggregated Revenue - We disaggregate our revenues into two categories: (i) software and related services; and (ii) engineered products and related services. Software and related services revenues are primarily derived from our Application Software and Network Software & Systems reportable segments. Engineered products and related services revenues are derived from all of our reportable segments except Application Software and comprise substantially all of the revenues generated in our Measurement & Analytical Solutions and Process Technologies reportable segments. See details in the table below.

	Three Months Ended March 31,
	2021		2020
Software and related services	$	864.5	$	668.5
Engineered products and related services	664.1		682.2
Net revenues	$	1,528.6	$	1,350.7

Remaining performance obligations - Remaining performance obligations represent the transaction price of firm orders for which work has not been performed and excludes unexercised contract options. As of March 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations was $4,102.4. We expect to recognize revenue on

approximately 63% of our remaining performance obligations over the next 12 months (“Backlog”), with the remainder to be recognized thereafter.

Contract balances

Balance Sheet Account	March 31, 2021		December 31, 2020		Change
Unbilled receivables	$	268.0	$	241.7	$	26.3
Contract liabilities - current (1)	(1,036.9)		(1,012.0)		(24.9)
Deferred revenue - non-current (2)	(76.4)		(43.1)		(33.3)
Net contract assets/(liabilities)	$	(845.3)	$	(813.4)	$	(31.9)

(1) Consists of “Deferred revenue,” and billings in-excess of revenues (“BIE”). BIE is reported in “Other accrued liabilities” in our Condensed Consolidated Balance Sheets.

(2) The non-current portion of deferred revenue is included in “Other liabilities” in our Condensed Consolidated Balance Sheets.

The change in our net contract assets/(liabilities) from December 31, 2020 to March 31, 2021 was due primarily to the timing of payments and invoicing relating to Software-as-a-Service (“SaaS”) and post contract support (“PCS”) renewals, partially offset by the increase in unbilled receivables associated with timing of invoicing in our project-based businesses, most notably our Transcore business.

Most of the Company’s project-based contracts where the input method of revenue recognition is utilized are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Often this results in billing occurring after revenue recognition resulting in contract assets. The Company records contract liabilities when cash payments are received or due in advance of the Company’s performance relating primarily to SaaS and PCS renewals. Revenue recognized during the three months ended March 31, 2021 and 2020 that was included in the contract liability balance on December 31, 2020 and 2019 was $459.1 and $323.5, respectively.

In order to determine revenues recognized in the period from contract liabilities, we allocate revenue to the individual deferred revenue or billings in-excess of revenues balance outstanding at the beginning of the year until the revenue exceeds that balance.

Impairment losses recognized on our accounts receivable and unbilled receivables were immaterial in the three months ended March 31, 2021.

XML

Recent Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2021

Accounting Standards Update and Change in Accounting Principle [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Financial Accounting Standards Board FASB (“FASB”) establishes changes to accounting principles under GAAP in the form of accounting standards updates (“ASUs”) to the Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. Any recent ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s results of operations, financial position or cash flows.

Recently Adopted Accounting Pronouncements

The Company adopted ASC Topic 326, Financial Instruments - Credit Losses (“ASC 326”), as of January 1, 2020 using the modified retrospective transition method. This ASU amends the impairment model to utilize an expected loss methodology in place of the incurred loss methodology for financial instruments, including trade receivables, and unbilled receivables. We recorded a noncash cumulative effect decrease to retained earnings of $1.7, net of income taxes, on our opening consolidated balance sheet as of January 1, 2020.

XML

Weighted Average Shares Outstanding (Tables)

3 Months Ended

Mar. 31, 2021

Earnings Per Share [Abstract]

Schedule of Weighted Average Shares Outstanding

Weighted average shares outstanding are shown below:

	Three months ended March 31,
	2021	2020
Basic shares outstanding	105.0	104.3
Effect of potential common stock:
Common stock awards	1.0	1.0
Diluted shares outstanding	106.0	105.3

XML

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Stock Based Compensation Expense

The following table provides information regarding the Company’s stock-based compensation expense:

	Three Months Ended March 31,
	2021		2020
Stock-based compensation	$	32.9	$	27.7
Tax effect recognized in net earnings	6.9		5.8

Weighted Average Assumptions Used to Value Option Grants

The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:

	Three months ended March 31,
	2021	2020
Risk-free interest rate (%)	0.94	0.83
Expected option life (years)	5.61	5.64
Expected volatility (%)	25.16	20.18
Expected dividend yield (%)	0.56	0.62

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Inventories

The components of inventory were as follows:

	March 31, 2021		December 31, 2020
Raw materials and supplies	$	134.0	$	128.4
Work in process	30.3		28.2
Finished products	83.4		82.2
Inventory reserves	(41.7)		(40.4)
Inventories, net	$	206.0	$	198.4

XML

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The carrying value of goodwill by segment was as follows:

	Application Software		Network Software & Systems		Measurement & Analytical Solutions		Process Technologies		Total
Balances at December 31, 2020	$	8,802.3	$	4,083.1	$	1,190.8	$	319.0	$	14,395.2
Additions	—		—		—		—		—
Other	(4.0)		0.7		—		—		(3.3)
Currency translation adjustments	3.5		10.4		(0.7)		0.2		13.4
Balances at March 31, 2021	$	8,801.8	$	4,094.2	$	1,190.1	$	319.2	$	14,405.3

Other Intangible Assets - Subject to Amortization

Other intangible assets were comprised of:

	Cost		Accumulated amortization		Net book value
Assets subject to amortization:
Customer related intangibles	$	7,494.7	$	(1,703.8)	$	5,790.9
Unpatented technology	942.8		(363.9)		578.9
Software	172.4		(127.4)		45.0
Patents and other protective rights	13.0		(6.7)		6.3
Trade names	7.3		(5.6)		1.7
Assets not subject to amortization:
Trade names	784.1		—		784.1
Balances at December 31, 2020	$	9,414.3	$	(2,207.4)	$	7,206.9
Assets subject to amortization:
Customer related intangibles	$	7,499.6	$	(1,817.2)	$	5,682.4
Unpatented technology	943.3		(392.4)		550.9
Software	172.5		(131.3)		41.2
Patents and other protective rights	13.3		(6.9)		6.4
Trade names	7.3		(5.9)		1.4
Assets not subject to amortization:
Trade names	784.5		—		784.5
Balances at March 31, 2021	$	9,420.5	$	(2,353.7)	$	7,066.8

Other Intangible Assets - Not Subject to Amortization

Other intangible assets were comprised of:

	Cost		Accumulated amortization		Net book value
Assets subject to amortization:
Customer related intangibles	$	7,494.7	$	(1,703.8)	$	5,790.9
Unpatented technology	942.8		(363.9)		578.9
Software	172.4		(127.4)		45.0
Patents and other protective rights	13.0		(6.7)		6.3
Trade names	7.3		(5.6)		1.7
Assets not subject to amortization:
Trade names	784.1		—		784.1
Balances at December 31, 2020	$	9,414.3	$	(2,207.4)	$	7,206.9
Assets subject to amortization:
Customer related intangibles	$	7,499.6	$	(1,817.2)	$	5,682.4
Unpatented technology	943.3		(392.4)		550.9
Software	172.5		(131.3)		41.2
Patents and other protective rights	13.3		(6.9)		6.4
Trade names	7.3		(5.9)		1.4
Assets not subject to amortization:
Trade names	784.5		—		784.5
Balances at March 31, 2021	$	9,420.5	$	(2,353.7)	$	7,066.8

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2021

Fair Value Disclosures [Abstract]

Fixed-Rate Senior Notes, Fair Value

Roper’s debt at March 31, 2021 included $8,000 of fixed-rate senior notes with the following fair values:

$500 2.800% senior notes due 2021	508
$500 3.125% senior notes due 2022	518
$300 0.450% senior notes due 2022	300
$700 3.650% senior notes due 2023	750
$500 2.350% senior notes due 2024	523
$300 3.850% senior notes due 2025	332
$700 1.000% senior notes due 2025	689
$700 3.800% senior notes due 2026	778
$700 1.400% senior notes due 2027	677
$800 4.200% senior notes due 2028	902
$700 2.950% senior notes due 2029	730
$600 2.000% senior notes due 2030	574
$1,000 1.750% senior notes due 2031	929

XML

Business Segments (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Segment Reporting Information

Net revenues and operating profit by segment are set forth in the following table:

	Three months ended March 31,
	2021		2020		Change %
Net revenues:
Application Software	$	576.6	$	405.1	42.3	%
Network Software & Systems	440.2		438.2		0.5	%
Measurement & Analytical Solutions	381.0		365.2		4.3	%
Process Technologies	130.8		142.2		(8.0)	%
Total	$	1,528.6	$	1,350.7	13.2	%
Gross profit:
Application Software	$	398.7	$	270.4	47.4	%
Network Software & Systems	299.4		293.2		2.1	%
Measurement & Analytical Solutions	224.7		214.6		4.7	%
Process Technologies	71.0		78.6		(9.7)	%
Total	$	993.8	$	856.8	16.0	%
Operating profit*:
Application Software	$	153.7	$	97.6	57.5	%
Network Software & Systems	135.5		138.7		(2.3)	%
Measurement & Analytical Solutions	124.1		114.0		8.9	%
Process Technologies	38.3		43.3		(11.5)	%
Total	$	451.6	$	393.6	14.7	%
Long-lived assets:
Application Software	$	126.7	$	85.1	48.9	%
Network Software & Systems	44.8		48.5		(7.6)	%
Measurement & Analytical Solutions	35.4		39.1		(9.5)	%
Process Technologies	19.5		21.0		(7.1)	%
Total	$	226.4	$	193.7	16.9	%

*Segment operating profit is before unallocated corporate general and administrative expenses; these expenses were $51.1 and $44.4 for the three months ended March 31, 2021 and 2020, respectively.

XML

Revenues from Contracts (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

	Three Months Ended March 31,
	2021		2020
Software and related services	$	864.5	$	668.5
Engineered products and related services	664.1		682.2
Net revenues	$	1,528.6	$	1,350.7

Contract Balances

Contract balances

Balance Sheet Account	March 31, 2021		December 31, 2020		Change
Unbilled receivables	$	268.0	$	241.7	$	26.3
Contract liabilities - current (1)	(1,036.9)		(1,012.0)		(24.9)
Deferred revenue - non-current (2)	(76.4)		(43.1)		(33.3)
Net contract assets/(liabilities)	$	(845.3)	$	(813.4)	$	(31.9)

(1) Consists of “Deferred revenue,” and billings in-excess of revenues (“BIE”). BIE is reported in “Other accrued liabilities” in our Condensed Consolidated Balance Sheets.

(2) The non-current portion of deferred revenue is included in “Other liabilities” in our Condensed Consolidated Balance Sheets.

XML

Basis of Presentation (Details) - Sedaru, Inc. $ in Millions	Mar. 17, 2021 USD ($)
Noncontrolling Interest [Line Items]
Sale of investment	$ 27.1
Pretax gain on sale of investment	$ 27.1

XML

Recent Accounting Pronouncements (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity	$ 10,765.7	$ 10,479.8	$ 9,591.3	$ 9,491.9
Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity	$ 8,776.0	8,546.2	$ 8,003.1	7,818.0
Cumulative Effect, Period Of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity				(1.7)
Cumulative Effect, Period Of Adoption, Adjustment | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' equity		$ (1.7)		$ (1.7)

XML

Weighted Average Shares Outstanding (Schedule of Weighted Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Basic shares outstanding (in shares)	105.0	104.3
Effect of potential common stock:
Common stock awards (in shares)	1.0	1.0
Diluted shares outstanding (in shares)	106.0	105.3

XML

Weighted Average Shares Outstanding (Narrative) (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Earnings Per Share [Abstract]
Antidilutive stock options (in shares)	647	1,318

XML

Stock Based Compensation (Stock Based Compensation Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock-based compensation	$ 32.9	$ 27.7
Tax effect recognized in net earnings	$ 6.9	$ 5.8

XML

Stock Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions			3 Months Ended
	Jul. 01, 2020	Jun. 30, 2020	Mar. 31, 2021	Mar. 31, 2020
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee stock options granted during the period (in shares)			498	725
Fair value per share (in dollars per share)			$ 94.69	$ 62.02
Cash received from exercise of options			$ 19.2	$ 22.9
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock awards granted during period (in shares)			207	179
Weighted average fair value per share of restricted stock awards granted during the period (in dollars per share)			$ 404.14	$ 340.92
Restricted stock awards vested during period (in shares)			116
Weighted average grant date fair value per share (in dollars per share)			$ 311.33
Weighted average vest date fair value per share (in dollars per share)			$ 394.23
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan	10.00%	10.00%
Discount on the average closing price for the employee stock purchase plan	10.00%	5.00%
Shares of stock purchased during the period by participants in the employee stock purchase plan (in shares)			13	8
Amount paid for stock purchased during the period by participants in the employee stock purchase plan			$ 4.7	$ 2.8

XML

Stock Based Compensation (Weighted Average Assumptions Used to Value Option Grants) (Details) - Employee Stock Option	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate (%)	0.94%	0.83%
Expected option life (years)	5 years 7 months 9 days	5 years 7 months 20 days
Expected volatility (%)	25.16%	20.18%
Expected dividend yield (%)	0.56%	0.62%

XML

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Inventories [Abstract]
Raw materials and supplies	$ 134.0	$ 128.4
Work in process	30.3	28.2
Finished products	83.4	82.2
Inventory reserves	(41.7)	(40.4)
Inventories, net	$ 206.0	$ 198.4

XML

Goodwill and Other Intangible Assets (Goodwill) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2021 USD ($)
Goodwill [Roll Forward]
Balances	$ 14,395.2
Additions	0.0
Other	(3.3)
Currency translation adjustments	13.4
Balances	14,405.3
Application Software
Goodwill [Roll Forward]
Balances	8,802.3
Additions	0.0
Other	(4.0)
Currency translation adjustments	3.5
Balances	8,801.8
Network Software & Systems
Goodwill [Roll Forward]
Balances	4,083.1
Additions	0.0
Other	0.7
Currency translation adjustments	10.4
Balances	4,094.2
Measurement & Analytical Solutions
Goodwill [Roll Forward]
Balances	1,190.8
Additions	0.0
Other	0.0
Currency translation adjustments	(0.7)
Balances	1,190.1
Process Technologies
Goodwill [Roll Forward]
Balances	319.0
Additions	0.0
Other	0.0
Currency translation adjustments	0.2
Balances	$ 319.2

XML

Goodwill and Other Intangible Assets (Other Intangible Assets) (Details) - USD ($) $ in Millions	Mar. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	$ (2,353.7)	$ (2,207.4)
Intangible assets, gross (excluding goodwill)	9,420.5	9,414.3
Intangible assets, net (excluding goodwill)	7,066.8	7,206.9
Trade names
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	784.5	784.1
Customer related intangibles
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	7,499.6	7,494.7
Accumulated amortization	(1,817.2)	(1,703.8)
Finite-lived intangible assets, net	5,682.4	5,790.9
Unpatented technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	943.3	942.8
Accumulated amortization	(392.4)	(363.9)
Finite-lived intangible assets, net	550.9	578.9
Software
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	172.5	172.4
Accumulated amortization	(131.3)	(127.4)
Finite-lived intangible assets, net	41.2	45.0
Patents and other protective rights
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	13.3	13.0
Accumulated amortization	(6.9)	(6.7)
Finite-lived intangible assets, net	6.4	6.3
Trade names
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	7.3	7.3
Accumulated amortization	(5.9)	(5.6)
Finite-lived intangible assets, net	$ 1.4	$ 1.7

XML

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 146.6	$ 101.8
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 145.4	$ 100.7

XML

Fair Value of Financial Instruments (Details) - Senior Notes - Fair Value, Inputs, Level 2	Mar. 31, 2021 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed rate senior notes carrying amount	$ 8,000,000,000
$500 2.800% senior notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 500,000,000
Fixed interest rate	2.80%
Long-term debt, fair value	$ 508,000,000
$500 3.125% senior notes due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 500,000,000
Fixed interest rate	3.125%
Long-term debt, fair value	$ 518,000,000
$300 0.450% senior notes due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 300,000,000
Fixed interest rate	0.45%
Long-term debt, fair value	$ 300,000,000
$700 3.650% senior notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 700,000,000
Fixed interest rate	3.65%
Long-term debt, fair value	$ 750,000,000
$500 2.350% senior notes due 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 500,000,000
Fixed interest rate	2.35%
Long-term debt, fair value	$ 523,000,000
$300 3.850% senior notes due 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 300,000,000
Fixed interest rate	3.85%
Long-term debt, fair value	$ 332,000,000
$700 1.000% senior notes due 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 700,000,000
Fixed interest rate	1.00%
Long-term debt, fair value	$ 689,000,000
$700 3.800% senior notes due 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 700,000,000
Fixed interest rate	3.80%
Long-term debt, fair value	$ 778,000,000
$700 1.400% senior notes due 2027
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 700,000,000
Fixed interest rate	1.40%
Long-term debt, fair value	$ 677,000,000
$800 4.200% senior notes due 2028
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 800,000,000
Fixed interest rate	4.20%
Long-term debt, fair value	$ 902,000,000
$700 2.950% senior notes due 2029
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 700,000,000
Fixed interest rate	2.95%
Long-term debt, fair value	$ 730,000,000
$600 2.000% senior notes due 2030
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 600,000,000
Fixed interest rate	2.00%
Long-term debt, fair value	$ 574,000,000
$1,000 1.750% senior notes due 2031
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Face amount of debt	$ 1,000,000,000
Fixed interest rate	1.75%
Long-term debt, fair value	$ 929,000,000

XML

Contingencies (Details) individual in Millions	3 Months Ended
	Mar. 31, 2021 claim individual
Vertafore Litigation
Loss Contingencies [Line Items]
Number of pending putative class actions	3
Number of individuals represented by class actions | individual	27.7
Allen, et al. v. Vertafore, Inc.
Loss Contingencies [Line Items]
Number of pending putative class actions	2
Mulvey, et al. v. Vertafore, Inc.
Loss Contingencies [Line Items]
Number of pending putative class actions	1

XML

Business Segments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Segment Reporting Information [Line Items]
Net revenues:	$ 1,528.6	$ 1,350.7
Percent change in net revenues	13.20%
Gross profit:	$ 993.8	856.8
Percent change in gross profit	16.00%
Operating profit	$ 451.6	393.6
Percent change in operating profit	14.70%
Long-lived assets:	$ 226.4	193.7
Percent change in long-lived assets	16.90%
Corporate
Segment Reporting Information [Line Items]
Unallocated corporate general and administrative expenses	$ 51.1	44.4
Application Software
Segment Reporting Information [Line Items]
Net revenues:	$ 576.6	405.1
Percent change in net revenues	42.30%
Gross profit:	$ 398.7	270.4
Percent change in gross profit	47.40%
Operating profit	$ 153.7	97.6
Percent change in operating profit	57.50%
Long-lived assets:	$ 126.7	85.1
Percent change in long-lived assets	48.90%
Network Software & Systems
Segment Reporting Information [Line Items]
Net revenues:	$ 440.2	438.2
Percent change in net revenues	0.50%
Gross profit:	$ 299.4	293.2
Percent change in gross profit	2.10%
Operating profit	$ 135.5	138.7
Percent change in operating profit	(2.30%)
Long-lived assets:	$ 44.8	48.5
Percent change in long-lived assets	(7.60%)
Measurement & Analytical Solutions
Segment Reporting Information [Line Items]
Net revenues:	$ 381.0	365.2
Percent change in net revenues	4.30%
Gross profit:	$ 224.7	214.6
Percent change in gross profit	4.70%
Operating profit	$ 124.1	114.0
Percent change in operating profit	8.90%
Long-lived assets:	$ 35.4	39.1
Percent change in long-lived assets	(9.50%)
Process Technologies
Segment Reporting Information [Line Items]
Net revenues:	$ 130.8	142.2
Percent change in net revenues	(8.00%)
Gross profit:	$ 71.0	78.6
Percent change in gross profit	(9.70%)
Operating profit	$ 38.3	43.3
Percent change in operating profit	(11.50%)
Long-lived assets:	$ 19.5	$ 21.0
Percent change in long-lived assets	(7.10%)

XML

Revenues from Contracts (Disaggregation of Revenue) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Disaggregation of Revenue [Line Items]
Net revenues	$ 1,528.6	$ 1,350.7
Software and related services
Disaggregation of Revenue [Line Items]
Net revenues	864.5	668.5
Engineered products and related services
Disaggregation of Revenue [Line Items]
Net revenues	$ 664.1	$ 682.2

XML

Revenues from Contracts (Remaining Performance Obligations Narrative) (Details) $ in Millions	Mar. 31, 2021 USD ($)
Revenue from Contract with Customer [Abstract]
Remaining performance obligations	$ 4,102.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations, percentage	63.00%
Remaining performance obligations, expected timing of satisfaction	12 months

XML

Revenues from Contracts (Contract Balances) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Unbilled receivables	$ 268.0	$ 241.7
Contract liabilities - current	(1,036.9)	(1,012.0)
Deferred revenue - non-current	(76.4)	(43.1)
Net contract assets/(liabilities)	(845.3)	$ (813.4)
Change in unbilled receivables	26.3
Change in contract liabilities - current	(24.9)
Change in deferred revenue - non-current	(33.3)
Change in net contract assets/(liabilities)	$ (31.9)

XML

Revenues from Contracts (Contract Balances - Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Contract with customer, revenues recognized	$ 459.1	$ 323.5

XML

Label	Element	Value
Accounting Standards Update [Extensible List]	us-gaap_AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member